Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven T Rosen

Showing results (1-10 of 214) with videos related to

Pageof 22
Sort By:
Seminars in Oncology|February 1, 2017
IntroductionSteven T Rosen
Clinical Advances in Hematology & Oncology : H&O|August 4, 2007
Advances in the treatment of primary cutaneous T-cell lymphomaSteven T Rosen
Cancer Biology & Therapy|October 20, 2004
Lessons learned pursuing translational researchSteven T Rosen
Current Opinion in Oncology|January 1, 2005
Mechanisms of glucocorticoid-induced apoptosis in hematologic malignancies: updatesOlga Frankfurt, Steven T Rosen
Oncology (Williston Park, N.Y.)|March 17, 2015
Novel biologic agents for non-Hodgkin lymphoma and chronic lymphocytic leukemia-part 1Tanya Siddiqi, Steven T Rosen
JAMA|December 3, 2014
Chronic lymphocytic leukemia: a clinical reviewChadi Nabhan, Steven T Rosen
Hematology. American Society of Hematology. Education Program|November 25, 2006
Primary cutaneous T-cell lymphomasSteven T Rosen, Christiane Querfeld
Oncology (Williston Park, N.Y.)|April 30, 2015
Novel biologic agents for non-Hodgkin lymphoma and chronic lymphocytic leukemia-part 2: adoptive cellular immunotherapy, small-molecule inhibitors, and immunomodulationTanya Siddiqi, Steven T Rosen
Current Opinion in Oncology|October 2, 2007
EnzastaurinShuo Ma, Steven T Rosen
Current Opinion in Oncology|September 6, 2011
Signal transduction inhibitors in chronic lymphocytic leukemiaShuo Ma, Steven T Rosen
Pageof 22

Showing results (1-10 of 214) with videos related to

Sort By:
Pageof 22
Seminars in Oncology|February 1, 2017
IntroductionSteven T Rosen
Clinical Advances in Hematology & Oncology : H&O|August 4, 2007
Advances in the treatment of primary cutaneous T-cell lymphomaSteven T Rosen
Cancer Biology & Therapy|October 20, 2004
Lessons learned pursuing translational researchSteven T Rosen
Current Opinion in Oncology|January 1, 2005
Mechanisms of glucocorticoid-induced apoptosis in hematologic malignancies: updatesOlga Frankfurt, Steven T Rosen
Oncology (Williston Park, N.Y.)|March 17, 2015
Novel biologic agents for non-Hodgkin lymphoma and chronic lymphocytic leukemia-part 1Tanya Siddiqi, Steven T Rosen
JAMA|December 3, 2014
Chronic lymphocytic leukemia: a clinical reviewChadi Nabhan, Steven T Rosen
Hematology. American Society of Hematology. Education Program|November 25, 2006
Primary cutaneous T-cell lymphomasSteven T Rosen, Christiane Querfeld
Oncology (Williston Park, N.Y.)|April 30, 2015
Novel biologic agents for non-Hodgkin lymphoma and chronic lymphocytic leukemia-part 2: adoptive cellular immunotherapy, small-molecule inhibitors, and immunomodulationTanya Siddiqi, Steven T Rosen
Current Opinion in Oncology|October 2, 2007
EnzastaurinShuo Ma, Steven T Rosen
Current Opinion in Oncology|September 6, 2011
Signal transduction inhibitors in chronic lymphocytic leukemiaShuo Ma, Steven T Rosen
Pageof 22